November 7, 1995 - Quintiles establishes the Quintiles Emerging Companies Institute to offer small companies access to development services.

November 3, 1995 - Quintiles elects Eric J. Souêtre, M.D., Ph.D. to the Board of Directors.

November 3, 1995 - Quintiles elects Rachel R. Selisker to the board of directors, effective November 3, 1995.

November 3, 1995 - Quintiles elects Sara Brooks Creagh to the Board of Directors.

October 25, 1995 - Quintiles Transnational Corp. (NASDAQ-NNM: QTRN) reported today record financial results for the third quarter ending September 30, 1995.

July 26, 1995 - Quintiles Transnational Corp. (NASDAQ-NNM: QTRN) reported today financial results for the second quarter ending June 30, 1995.

April 26, 1995 - Quintiles reported today financial results for the first quarter ending March 31, 1995.

March 6, 1995 - Quintiles Scotland Ltd. completes agreements to acquire certain assets of a drug development facility in Edinburgh.

February 8, 1995 - Quintiles Transnational Corp. (NASDAQ-NNM: QTRN) reported today financial results for the quarter and year ending December 31, 1994.

January 17, 1995 - Quintiles (UK) Limited has signed a non-binding letter of intent to acquire certain assets from Syntex Pharmaceutical.